These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30447295)

  • 1. Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements.
    Rangaraj N; Pailla SR; Sampathi S
    Pulm Pharmacol Ther; 2019 Feb; 54():1-21. PubMed ID: 30447295
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers.
    Al-Hallak MH; Sarfraz MK; Azarmi S; Roa WH; Finlay WH; Löbenberg R
    Ther Deliv; 2011 Oct; 2(10):1313-24. PubMed ID: 22826885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the development of microparticles for pulmonary administration.
    Jain H; Bairagi A; Srivastava S; Singh SB; Mehra NK
    Drug Discov Today; 2020 Oct; 25(10):1865-1872. PubMed ID: 32712311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle engineering for pulmonary drug delivery.
    Chow AH; Tong HH; Chattopadhyay P; Shekunov BY
    Pharm Res; 2007 Mar; 24(3):411-37. PubMed ID: 17245651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conference report: 1st Medicon Valley Inhalation Symposium.
    Lastow O
    Ther Deliv; 2013 Feb; 4(2):149-51. PubMed ID: 23343154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary drug delivery: medicines for inhalation.
    Henning A; Hein S; Schneider M; Bur M; Lehr CM
    Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary delivery of therapeutic compounds for treating CNS disorders.
    Noymer P; Biondi S; Myers D; Cassella J
    Ther Deliv; 2011 Sep; 2(9):1125-40. PubMed ID: 22833910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition, imaging, and clearance: what remains to be done?
    Scheuch G; Bennett W; Borgström L; Clark A; Dalby R; Dolovich M; Fleming J; Gehr P; Gonda I; O'Callaghan C; Taylor G; Newman S
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S39-57. PubMed ID: 21133799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects and challenges: inhalation delivery systems.
    Niven R
    Ther Deliv; 2013 May; 4(5):519-22. PubMed ID: 23647267
    [No Abstract]   [Full Text] [Related]  

  • 15. Current approaches to the discovery of novel inhaled medicines.
    Strong P; Ito K; Murray J; Rapeport G
    Drug Discov Today; 2018 Oct; 23(10):1705-1717. PubMed ID: 29775668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ and in vivo methods for pulmonary delivery.
    Eljamal M; Nagarajan S; Patton JS
    Pharm Biotechnol; 1996; 8():361-74. PubMed ID: 8791819
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of particle size on regional lung deposition--what evidence is there?
    Carvalho TC; Peters JI; Williams RO
    Int J Pharm; 2011 Mar; 406(1-2):1-10. PubMed ID: 21232585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung physiology and aerosol deposition imaged with positron emission tomography.
    Venegas J; Winkler T; Harris RS
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):1-8. PubMed ID: 22856557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.